Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus

British Journal of Dermatology

Volumn 162, Issue 4, 2010, Pages 790-797

  Saha, M ^a   Powell, A M ^a   Bhogal, B ^a   Black, M M ^a   Groves, R W ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Cyclophosphamide; Pemphigus; Pulsed methylprednisolone; Treatment

Indexed keywords

ANTIBIOTIC AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 3 ANTIBODY; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; AMENORRHEA; ANTIBODY TITER; ARTICLE; BACTERIAL SKIN DISEASE; BLEPHARITIS; CANDIDIASIS; CATARACT; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG RESPONSE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EARLY MENOPAUSE; FATIGUE; FEMALE; GLUCOSURIA; HEARING LOSS; HERPES ZOSTER; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; LASSITUDE; LOW DRUG DOSE; LUNG CARCINOMA; LYMPHOCYTOPENIA; MALE; MUSCULOSKELETAL PAIN; NAUSEA; OTALGIA; PARANEOPLASTIC PEMPHIGUS; PARONYCHIA; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PLASMAPHERESIS; PNEUMONIA; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; SEPSIS; SIDE EFFECT; THROMBOCYTOPENIA; URINARY FREQUENCY; WEIGHT GAIN; DRUG COMBINATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PROCEDURES; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PEMPHIGUS; TREATMENT OUTCOME;

EID: 77949839464     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09590.x     Document Type: Article

References (30)

1. Pandya AG, Sontheimer RD. Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide. Arch Dermatol 1992 128 : 1626 1630.
2. Rosenberg FR, Sanders S, Nelson CT. Pemphigus: a 20-year review of 107 patients treated with corticosteroids. Arch Dermatol 1976 112 : 962 970.
3. Harman KE, Albert S, Black MM. Guidelines for the management of pemphigus vulgaris. Br J Dermatol 2003 149 : 926 937.
4. Cupps TR, Edgar LC, Fauci AS. Suppression of human B lymphocyte function by cyclophosphamide. J Immunol 1982 128 : 2453 2457.
5. Werth VP. Pulse intravenous cyclophosphamide for treatment of autoimmune blistering disease. Is there an advantage over oral routes? Arch Dermatol 1997 133 : 229 230.
6. Steinberg AD. Cyclophosphamide: should it be used daily, monthly, or never? N Engl J Med 1984 310 : 458 459.
7. Fox LP, Pandya AG. Pulse intravenous cyclophosphamide therapy for dermatologic disorders. Dermatol Clin 2000 18 : 459 473.
8. Pasricha JS, Khaitan BK, Raman RS, Chandra M. Dexamethasone- cyclophosphamide pulse therapy for pemphigus. Int J Dermatol 1995 34 : 875 882.
9. Sacchidanand S, Hiremath NC, Natraj HV et al. Dexamethasone- cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria Hospital, Bangalore. Dermatol Online J 2003 9 : 2.
10. Kaur S, Kanwar AJ. Dexamethasone-cyclophosphamide pulse therapy in pemphigus. Int J Dermatol 1990 29 : 371 374.
11. Kanwar AJ, Kaur S, Thami GP. Long-term efficacy of dexamethasone- cyclophosphamide pulse therapy in pemphigus. Dermatology 2002 204 : 228 231.
12. Fleischli ME, Valek RH, Pandya AG. Pulse intravenous cyclophosphamide therapy in pemphigus. Arch Dermatol 1999 135 : 57 61.
13. Citarrella P, Gebbia V, Di Marco P et al. Cyclophosphamide plus vincristine and prednisone in the treatment of severe pemphigus vulgaris refractory to conventional therapy. J Chemother 1992 4 : 56 8.
14. Chams-Davatchi C, Esmaili N, Daneshpazhooh M et al. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. J Am Acad Dermatol 2007 57 : 622 628.
15. Rose E, Wever S, Zilliken D et al. Intravenous dexamethasone- cyclophosphamide pulse therapy in comparison with oral methylprednisolone- azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study. J Dtsch Dermatol Ges 2005 3 : 200 206.
16. Harman KE, Seed PT, Gratian MJ et al. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 2001 144 : 775 780.
17. Harman KE, Gratian MJ, Seed PT et al. Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3. Clin Exp Dermatol 2000 25 : 236 240.
18. Ahmed AR, Hombal SM. Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical uses. J Am Acad Dermatol 1984 11 : 1115 1126.
19. Mayes MD, Wooley P, Mosley A et al. Intravenous pulse cyclophosphamide treatment for SLE and the risk of malignancy. Arthritis Rheum 1995 38 : 906.
20. Buttgereit F, Straub RH, Wehling M et al. Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action. Arthritis Rheum 2004 50 : 3408 3417.
21. Le Thi HD, Papo T, Piette JC et al. Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis. Clin Exp Rheumatol 1996 14 : 9 16.
22. Bhat R, Sharma VK, Ramam M, Kumar A. Cyclophosphamide pulses with oral prednisolone in the treatment of pemphigus: a pilot study. Dermatol Online J 2005 11 : 4.
23. Musette P, Pascal F, Hoang-Xuan T et al. Treatment of cicatricial pemphigoid with pulse intravenous cyclophosphamide. Arch Dermatol 2001 137 : 101 102.
24. Austin HA III., Klippel JH, Balow JE et al. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986 314 : 614 619.
25. Hayag MV, Cohen JA, Kerdel FA. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris. J Am Acad Dermatol 2000 43 : 1065 1069.
26. Cohen MA, Cohen JJ, Kerdel FA. Immunoablative high-dose cyclophosphamide without stem cell rescue in pemphigus foliaceus. Int J Dermatol 2002 41 : 340 344.
27. Mahajan VK, Sharma NL, Sharma RC et al. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases. Int J Dermatol 2005 44 : 821 827.
28. Baum S, Scope A, Barzilai A et al. The role of IVIg treatment in severe pemphigus vulgaris. J Eur Acad Dermatol Venereol 2006 20 : 548 552.
29. Eming R, Hertl M. Immunoadsorption in pemphigus. Autoimmunity 2006 39 : 609 616.
30. Morrison LH. Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab). J Am Acad Dermatol 2004 51 : 817 819.